Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junki Mizusawa

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 10, 2024
Reply to letter to the editor: "5-year follow-up results of a JCOG1104 (OPAS-1) phase III noninferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer"Takaki Yoshikawa, Masanori Terashima, Junki Mizusawa
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 17, 2017
Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trialsDaisuke Takahari, Junki Mizusawa, Wasaburo Koizumi, et al.
Statistics in Medicine|February 4, 2026
Adaptive Seamless Phase II/III Randomization Test Considering Treatment Group Selection Based on Short-Term Binary OutcomesFunato Sato, Kohei Uemura, Junki Mizusawa, et al.
Oncotarget|February 22, 2018
An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)Yasumasa Ezoe, Junki Mizusawa, Hiroshi Katayama, et al.
Japanese Journal of Clinical Oncology|July 23, 2019
Study risk assessment of Japan Clinical Oncology Group (JCOG) clinical trials using the European Organisation for Research and Treatment of Cancer (EORTC) study risk calculatorKenichi Miyamoto, Kenichi Nakamura, Junki Mizusawa, et al.
Cureus|June 24, 2024
Statistical Analysis Methods and Reporting of Patient-Reported Outcomes in Randomized Controlled Trials for Cancer Conducted in Japan: A Systematic ReviewJunki Mizusawa, Gakuto Ogawa, Mitsumi Terada, et al.
Cancer Medicine|July 31, 2023
Racial differences in longitudinal toxicities of anticancer agents in early phase cancer clinical trialsJunki Mizusawa, Hioryuki Sato, Larry V Rubinstein, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 29, 2016
Institutional variation in short- and long-term outcomes after surgery for gastric or esophagogastric junction adenocarcinoma: correlative study of two randomized phase III trials (JCOG9501 and JCOG9502)Yukinori Kurokawa, Takuhiro Yamaguchi, Mitsuru Sasako, et al.
Japanese Journal of Clinical Oncology|October 22, 2014
Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC)Akihiro Homma, Kenichi Nakamura, Kazuto Matsuura, et al.
Japanese Journal of Clinical Oncology|March 31, 2016
Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)Junki Mizusawa, Chigusa Morizane, Takuji Okusaka, et al.
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 10, 2024
Reply to letter to the editor: "5-year follow-up results of a JCOG1104 (OPAS-1) phase III noninferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer"Takaki Yoshikawa, Masanori Terashima, Junki Mizusawa
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 17, 2017
Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trialsDaisuke Takahari, Junki Mizusawa, Wasaburo Koizumi, et al.
Statistics in Medicine|February 4, 2026
Adaptive Seamless Phase II/III Randomization Test Considering Treatment Group Selection Based on Short-Term Binary OutcomesFunato Sato, Kohei Uemura, Junki Mizusawa, et al.
Oncotarget|February 22, 2018
An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)Yasumasa Ezoe, Junki Mizusawa, Hiroshi Katayama, et al.
Japanese Journal of Clinical Oncology|July 23, 2019
Study risk assessment of Japan Clinical Oncology Group (JCOG) clinical trials using the European Organisation for Research and Treatment of Cancer (EORTC) study risk calculatorKenichi Miyamoto, Kenichi Nakamura, Junki Mizusawa, et al.
Cureus|June 24, 2024
Statistical Analysis Methods and Reporting of Patient-Reported Outcomes in Randomized Controlled Trials for Cancer Conducted in Japan: A Systematic ReviewJunki Mizusawa, Gakuto Ogawa, Mitsumi Terada, et al.
Cancer Medicine|July 31, 2023
Racial differences in longitudinal toxicities of anticancer agents in early phase cancer clinical trialsJunki Mizusawa, Hioryuki Sato, Larry V Rubinstein, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 29, 2016
Institutional variation in short- and long-term outcomes after surgery for gastric or esophagogastric junction adenocarcinoma: correlative study of two randomized phase III trials (JCOG9501 and JCOG9502)Yukinori Kurokawa, Takuhiro Yamaguchi, Mitsuru Sasako, et al.
Japanese Journal of Clinical Oncology|October 22, 2014
Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC)Akihiro Homma, Kenichi Nakamura, Kazuto Matsuura, et al.
Japanese Journal of Clinical Oncology|March 31, 2016
Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)Junki Mizusawa, Chigusa Morizane, Takuji Okusaka, et al.
Pageof 20